Generation of receptor-active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro: A new assay to define factors affecting glycosphingolipid receptor activity

Glycoconjugate Journal

Volumn 20, Issue 1, 2003, Pages 33-38

  Nutikka, Anita ^a   Lingwood, Clifford ^a,b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Detergent resistant lipid microdomains; Sulfatide; Verotoxin

Indexed keywords

CARBOHYDRATE; CHOLESTEROL; FLUORESCEIN; GLOBOTRIAOSYLCERAMIDE; GLYCOLIPID; GLYCOSPHINGOLIPID; IODINE 125; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; RECEPTOR; SPHINGOMYELIN; SUCROSE; TYLOXAPOL; VEROTOXIN 1;

BINDING AFFINITY; CONFERENCE PAPER; DENSITY GRADIENT CENTRIFUGATION; DYNAMICS; LIGAND BINDING; LIPID MEMBRANE; MEMBRANE STRUCTURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; STRUCTURE ANALYSIS;

EID: 1642361189     PISSN: 02820080     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:GLYC.0000016740.69726.fb     Document Type: Conference Paper

References (59)

1. Thompson TT, TW, Organization of glycosphingolipids in bilayers and plasma membranes of mammalian cells, Ann Rev Biophys Biophys Chem 14, 361-86 (1985).
2. Simons K, Ehehalt R, Cholesterol, lipid rafts, and disease, J Clin Invest 110, 597-603 (2002).
3. Lingwood CA, Schachter H, Localization of sulfatoxygalactosylacylalkylglycerol at the surface of rat testicular germinal cells by immunocytochemical techniques: pH dependence of a nonimmunological reaction between immunoglobulin and germinal cells, J Cell Biol 89, 620-30 (1981).
4. Hooper N, Detergent-insoluble glycosphingolipid/cholesterolrich membrane domains, lipid rafts and caveolae, Molr Membr Biol 16, 145-56 (1999).
5. Falguieres T, Mallard F, Baron C, Hanau D, Lingwood C, Goud B, Salamero J, Johannes L, Targeting of Shiga toxin b-subunit to retrograde transport route in association with detergent-resistant membranes, Mol Biol Cell 12, 2453-68 (2001).
6. Taylor CM, Coetzee T, Pfeiffer SE, Detergent-insoluble glycosphingolipid/cholesterol microdomains of the myelin membrane, J Neurochem 81, 993-1004 (2002).
7. Lencer WI, Hirst TR, Holmes RK, Membrane traffic and the cellular uptake of cholera toxin (review), Biochim Biophys Acta 1450, 177-90 (1999).
8. Radhakrishnan A, Anderson TG, McConnell HM, Condensed complexes, rafts, and the chemical activity of cholesterol in membranes, Proc Natl Acad Sci 97, 12422-7 (2000).
9. Dietrich C, Bagatolli LA, Volovyk ZN, Thompson NL, Levi M, Jacobson K, Gratton E, Lipid rafts reconstituted in model membranes, Biophys J 80, 1417-28 (2001).
10. Mori T, Kiyokawa N, Katagiri YU, Taguchi T, Suzuki T, Sekino T, Sato N, Ohmi K, Nakajima H, Takeda T, Fukimoto J, Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating Lyn kinase activity in human B cells, Exp Hemat 28, 1260-8 (2000).
11. Kazui A, Ono M, Handa K, Hakomori S, Glycosylation affects translocation of integrin, Src, and caveolin into or out of GEM, Biochem Biophys Res Commun 273, 159-63 (2000).
12. Zhang Y, Iwabuchi K, Nunomura S, Hakomori S, Effect of synthetic sialyl 2→1 sphingosine and other glycosylsphingosines on the structure and function of the "glycosphingolipid signaling domain (GSD)" in mouse melanoma B16 cells, Biochem 39, 2459-68 (2000).
13. Simons K, Toomre D, Lipid rafts and signal transduction, Nature Rev 1, 31-9 (2000).
14. Chigorno V, Palestini P, Sciannamblo M, Dolo V, Pavan A, Tettamanti G, Sonnino S, Evidence that ganglioside enriched domains are distinct from caveolae in MDCKII and human fibroblast cells in culture, Eur J Biochem 267, 4187 (2000).
15. Iwabuchi K, Handa K, Hakomori S, Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling, J Biol Chem 273, 33766-73 (1998).
16. Anderson RG, Jacobson K, A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains, Science 296, 1821-5 (2002).
17. Smart E, Ying Y, Donzell W, Anderson R, A role for caveolin in transport of cholesterol from endoplasmic reticulum to plasma membrane, J Biol Chem 271, 29427-35 (1996).
18. Andreoli SP, Trachtman H, Acheson DW, Siegler RL, Obrig TG, Hemolytic uremic syndrome: Epidemiology, pathophysiology, and therapy, Pediatr Nephrol 17, 293-8 (2002).
19. Lingwood CA, Glycolipid receptors for verotoxin and Helicobacter pylori: Role in pathology, Biochim Biophys Acta 1455, 375-86 (1999).
20. Katagiri Y, Mori T, Nakajima H, Katagiri C, Taguchi T, Takeda T, Kiyokawa N, Fujimoto J, Activation of Src family kinase induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains, J Biol Chem 274, 35278-82 (1999).
21. Head S, Karmali M, Lingwood CA, Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits: Evidence for B subunit modulation of A subunit function, J Biol Chem 266, 3617-21 (1991).
22. Ramotar K, Boyd B, Tyrrell G, Gariepy J, Lingwood CA, Brunton J, Characterization of Shiga-like toxin 1 B subunit purified from overproducing clones of the SLT-1 B cistron, Biochem J 272, 805-11 (1990).
23. Khine AA, Lingwood CA, Capping and receptor mediated endocytosis of cell bound verotoxin(Shiga-like toxin) 1; Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization, J Cell Physiol 161, 319-32 (1994).
24. Pellizzari A, Pang H, Lingwood CA, Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content, Biochem 31, 1363-70 (1992).
25. Lingwood CA, Murray RK, Schachter H, The preparation of rabbit antiserum specific for mammalian testicular sulfogalactoglycerolipid, J Immunol 124, 769-74 (1980).
26. Simons K, Ikonen E, Functional rafts in cell membranes, Nature 387, 569-72 (1997).
27. Ait Slimane T, Hoekstra, D, Sphingolipid trafficking and protein sorting in epithelial cells, FEBS Lett 529, 54 (2002).
28. 3 interaction, J Lip Res 43, 1670-9 (2002).
29. Konno A, Nunogami K, Wada T, Yachie A, Suzuki Y, Takahashi N, Suzuki T, Miyamoto D, Kiso M, Hasegawa A, Miyawaki T, Inhibitory activity of sulfatide, a putative ligand for L-selectin, on B cell proliferation and Ig production, Int Immunol 8, 1905-13 (1996).
30. Ohta K, Sato C, Matsuda T, Toriyama M, Lennarz WJ, Kitajima K, Isolation and characterization of low density detergent-insoluble membrane (LD-DIM) fraction from sea urchin sperm, Biochem Biophys Res Comm 258, 616-23 (1999).
31. Kiarash A, Boyd B, Lingwood CA, Glycosphingolipid receptor function is modified by fatty acid content: Verotoxin 1 and Verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues, J Biol Chem 269, 11138-46 (1994).
32. Mamelak D, Mylvaganam M, Tanahashi E, Ito H, Ishida H, Kiso M, Lingwood C, The aglycone of sulfogalactolipids can alter the sulfate ester substitution position required for hsc70 recognition, Carbohydr Res 335, 91-100 (2001).
33. Mamelak D, Mylvaganam M, Whetstone H, Hartmann E, Lennarz W, Wyrick P, Raulston J, Han H, Hoffman P, Lingwood C, Hsp70s contain a specific sulfogalactolipid binding site. Differential aglycone influence on sulfogalactosyl ceramide binding by prokaryotic and eukaryotic hsp70 family members, Biochemistry 40, 3572-82 (2001).
34. Boyd B, Zhiuyan Z, Magnusson G, Lingwood CA, Lipid modulation of glycolipid receptor function: Presentation of galactose α1-4 galactose disaccharide for Verotoxin binding in natural and synthetic glycolipids, Eur J Biochem 223, 873-8 (1994).
35. Mamelak D, Lingwood C, Expression and sulfogalactolipid binding of the recombinant testis-specific cognate heat shock protein 70, Glycoconj J 14, 715-22 (1997).
36. Puri A, Hug P, Jernigan K, Barchi J, Kim H-Y, Hamilton J, Wiels J, Murray GJ, Brady RO, Blumenthal R, The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein, Proc Natl Acad Sci 95, 14435-40 (1998).
37. + cells, Virology 246, 211-20 (1998).
38. Mylvaganam M, Lingwood C, Adamantyl globotriaosyl ceramide-a monovalent soluble glycolipid mimic which inhibits verotoxin binding to its glycolipid receptor, Biochem Biophys Res Commun 257, 391-4 (1999).
39. 3Cer binding sites, Biochem J 368, 769-76 (2002).
40. Whetstone D, Lingwood C, 3'Sulfogalactolipid binding specifically inhibits Hsp70 ATPase activity in vitro, Biochem 42, 1611-7 (2003).
41. Schapiro F, Lingwood CA, Furuya W, Grinstein S, pH-independent targeting of glycolipids to the Golgi complex, Am J Physiol 274, 319-32 (1998).
42. Manes S, Lacalle R, Gomez-Mouton C, del Real G, Mira E, Martinez AC, Membrane raft microdomains in chemokine receptor function, Sem Immunol 13, 147-57 (2001).
43. Bini L, Pacini S, Liberatore S, Valensin S, Pellegrini M, Raggiaschi R, Pallini V, Baldari CT, Extensive temporally regulated reorganization of the lipid raft proteome following T cell antigen receptor triggering, Biochem J 2 (2002).
44. Manes S, del Real G, Lacalle RA, Lucas P, Gomez-Mouton C, Sanchez-Palomino S, Delgado R, Alcami J, Mira E, Martinez-AC, Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection, EMBO Reports 1, 190-6 (2000).
45. Fantini J, Hammache D, Pieroni G, Yahi N, Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion, Glycoconj J 17, 199-204 (2000).
46. Fantini J, Maresca M, Hammache D, Yahi N, Delezay O, Glycosphingolipid(GSL) microdomains as attachment platforms for host pathogens and their toxins on intestinal epithelial cells: Activation of signal transduction pathways and peturbations of intestinal absorption and secretion, Glycoconj J 17, 173-9 (2000).
47. Liao Z, Cimakasky LM, Hampton R, Nguyen DH, Hildreth JE, Lipid rafts and HIV pathogenesis: Host membrane cholesterol is required for infection by HIV type 1, AIDS Res Hum Retroviruses 17, 1009-19 (2001).
48. Watarai M, Makino S, Michikawa M, Yanagisawa K, Murakami S, Shirahata T, Macrophage plasma membrane cholesterol contributes to Brucella abortus infection of mice, Infect Immun 70, 4818-25 (2002).
49. Duncan M, Shin J, Abraham S, Microbial entry through caveoli: Variations on a theme, Cell Microbiol 4, 783-91 (2002).
50. Hakomori S-I, Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain, Glycoconjugate J 17, 143-51 (2000).
51. Lingwood CA, Aglycone modulation of glycolipid receptor function, Glycoconj J 13, 495-503 (1996).
52. Arab S, Lingwood CA, Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: Comparison of a surface bilayer film and liposomes, Glycoconj J 13, 159-66 (1996).
53. Iwabuchi K, Handa K, Hakomori S, Separation of glycosphingolipid- enriched microdomains from caveolar membrane characterized by presence of caveolin, Methods Enzymol 312, 488-94 (2000).
54. Pike LJ, Han X, Chung K-N, Gross RW, Lipid rafts are enriched in arachidonic acid and plasmeylethanolamine and their composition is independent of caveolin-1 expression: A quantitative electrospray ionization/mass spectrometric analysis, Biochem 41, 2075-88 (2002).
55. Kovbasnjuk O, Edidin M, Donowitz M, Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells, J Cell Sci 114, 4025-31 (2001).
56. Bhat S, Mettus R, Reddy E, Ugen K, Srikanthan V, Williams W, Weiner D, The galactosyl ceramide/sulfatide receptor binding region of HIV-1gp120 maps to amino acids 206-275, Aids Res Human Retrovirus 9, 175-81 (1993).
57. Delezay O, Hammache D, Fantini J, Yahi N, SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids, Biochemistry 35, 15663-71 (1996).
58. Hammache D, Piéroni G, Yahi N, Delézay O, Koch N, Lafont H, Tamalet C, Fantini J, Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosyl-ceramide and ganglioside GM3, J Biol Chem 273, 7967-71 (1998).
59. Wolf AA, Fujinaga Y, Lencer WI, Uncoupling of the cholera toxn-G(M1) ganglioside receptor complex from endocytosis, retrograde Golgi trafficking, and downstream signal transductionby depletion of membrane cholesterol, J Biol Chem 277, 16249-56 (2002).